WASHINGTON, May 3, 2023 (AFP) – The United States on Wednesday approved the world’s first vaccine for the Respiratory Syncytial Virus (RSV), the culmination of a decades-long hunt to protect vulnerable people from the common illness. Drugmaker GSK’s Arexvy was green-lighted for adults aged 60 and older, with similar shots from other makers including Pfizer and Moderna expected to follow soon. “Today’s approval of the first RSV vaccine is an important public health achievement to […]